Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
D. Li
Institution:
Henan Provincial People's Hospital
Observed institutions:
Henan Provincial People's Hospital,
Zhengzhou People's Hospital
OpenAlex ID:
A5021667734
1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trial
2025
·
H-C. Sun
, J. Fan
, et al.
·
Annals of Oncology
·
9
92P Safety of liver resection following atezolizumab plus bevacizumab treatment in hepatocellular carcinoma (HCC) patients with macrovascular invasion: A pre-specified analysis of the TALENTop study
2022
·
H. Sun
, F. Shen
, et al.
·
Annals of Oncology
·
5
PDF
Show more works
View as search
Works count:
2
Citation count:
15
H-index:
2
I10-index:
1
Year
Topic
Type